To include your compound in the COVID-19 Resource Center, submit it here.

Ipafricept: Phase Ib ongoing

OncoMed said FDA lifted a partial hold on the company's Phase Ib trials evaluating ipafricept. The trials are evaluating the product in combination with carboplatin and paclitaxel to treat recurrent platinum-sensitive ovarian cancer;

Read the full 336 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE